Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorJohns Hopkins University
About this trial
The goal of this clinical trial is to observe the impact of a surgeon-driven bone health referral pathway following lower extremity arthroplasty. The main question this study aims to answer is:
1\) What is impact of a surgeon-driven bone health referral pathway on implant-related complications and fragility fractures when compared to standard of care primary care provider referral.
Researchers will compare the endocrinology referral pathway and standard of care to see if there is a difference in treatment rates, fragility fractures, and implant-related complications following lower extremity arthroplasty.
Eligibility criteria
Qualifiers
>50
DEXA-confirmed diagnosis of osteoporosis
Disqualifiers
Prior diagnosis of osteoporosis
Prior treatment for osteoporosis
Trial design
Treatments tested in this trial
- Surgeon-Initiated Bone Health Referral Pathway
Treatment groups
2,000 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov